Tempus ECG-Low EF vs DeepTek CXR Analyzer

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Tempus
VS
by DeepTek

AI Verdict

Tool A specializes in analyzing ECGs to detect signs of low left ventricular ejection fraction, providing a binary output for heart failure risk assessment. In contrast, Tool B analyzes chest X-rays to identify and highlight a broad spectrum of lung, pleural, and cardiac pathologies, primarily assisting radiologists with diagnostic accuracy and workflow. While both are FDA-cleared AI solutions in cardiology, they operate on different imaging modalities and serve distinct diagnostic purposes within the cardiac care pathway.

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if your primary objective is to rapidly screen for potential low left ventricular ejection fraction (LVEF ≤40%) in patients aged 40 or older using standard 12-lead ECGs. This tool is ideal for aiding clinicians in the early identification of individuals at risk of heart failure who may require further cardiac evaluation.

View Tempus ECG-Low EF →

Choose DeepTek CXR Analyzer if…

Choose DeepTek CXR Analyzer if you aim to significantly improve the efficiency and diagnostic accuracy of chest X-ray interpretation across a broad spectrum of lung, pleural, and cardiac pathologies. This solution is best suited for radiology departments seeking to reduce radiologist workload, accelerate workflow, and automatically highlight suspicious regions for comprehensive review.

View DeepTek CXR Analyzer →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Tempus ECG-Low EF DeepTek CXR Analyzer
Pricing Unknown Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription.
Deployment Integrates with current ECG platforms and electronic health records (EHRs). On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DeepTek CXR Analyzer

DeepTek CXR Analyzer offers advanced features for workflow integration, including automatic identification, categorization, and highlighting of suspicious regions of interest, directly aiming to reduce radiologist workload by 30-50% and boost productivity by 2x-3x. While Tempus ECG-Low EF provides a clear binary output, DeepTek's comprehensive assistance within the radiologist's workflow provides a greater overall usability impact.

Clinical Value

DeepTek CXR Analyzer

Both tools are FDA-cleared and address significant clinical needs. DeepTek CXR Analyzer explicitly states it improves diagnostic accuracy by detecting 28 findings across various pathologies, with a study showing it outperformed unaided human readers and improved sensitivity and AUROC for test readers. Tempus ECG-Low EF aids in identifying patients at risk of heart failure, but DeepTek's direct impact on diagnostic accuracy for a broader range of common pathologies gives it a slight edge in immediate clinical value.

Pricing & Value

DeepTek CXR Analyzer

DeepTek CXR Analyzer offers more transparency regarding its pricing model, specifying 'Pay-per-use' and availability as a 'technology offering or an AI-assisted reporting service.' This provides potential customers with clearer options and a better understanding of the value alignment compared to Tempus ECG-Low EF, which only states 'contact vendor.'

Enterprise Readiness

DeepTek CXR Analyzer

Both tools demonstrate strong enterprise readiness with HIPAA compliance, BAA availability, and FDA clearance. However, DeepTek CXR Analyzer explicitly offers flexible deployment options including both 'Cloud' and 'On-premise' with seamless DICOM-based PACS integration, providing greater adaptability for diverse healthcare IT environments.

Innovation

Tempus ECG-Low EF

Tempus ECG-Low EF demonstrates a more novel application of AI by using standard 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction, a condition typically assessed by more specialized imaging like echocardiography. This innovative approach leverages existing, widely available data for early risk identification. DeepTek's broad detection capabilities for chest X-rays are impressive, but the core concept of CADe for X-rays is more established.

Support & Docs

DeepTek CXR Analyzer

Both companies provide clear contact information for customer support via email and phone. DeepTek, however, explicitly mentions a 'Resources Hub' that includes a 'Gateway Download & Installation Guide' and actively recruits for a Technical Support Engineer with expertise in DICOM and system integration, suggesting a more robust and specialized technical documentation and support structure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Tempus ECG-Low EF DeepTek CXR Analyzer
Name Tempus ECG-Low EF DeepTek CXR Analyzer
Company Tempus AI DeepTek Medical Imaging Pvt
Primary Modality/Input 12-lead ECG recordings Chest X-ray analysis
Target Condition/Pathology Low Left Ventricular Ejection Fraction (LVEF u226440%) 28 findings covering lung, pleural, cardiac pathologies, and hardware
Output Type Binary output (Low LVEF Detected / Not Detected) Automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs); Generates secondary capture DICOM with AI output

Videos

Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and DeepTek CXR Analyzer.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tempus ECG-Low EF is designed to analyze 12-lead ECGs to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure, aiding in further evaluation. DeepTek CXR Analyzer is an AI-powered CADe solution for chest X-ray analysis, assisting radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies to improve workflow efficiency and diagnostic accuracy.
Tempus ECG-Low EF analyzes resting, non-ambulatory 12-lead ECG recordings. DeepTek CXR Analyzer analyzes chest X-ray images and is compatible with various X-ray modalities, including hospital, mobile, portable, and handheld units.
Tempus ECG-Low EF provides a binary output (Low LVEF Detected / Not Detected) to aid clinicians in further evaluation, but it is not a standalone diagnostic tool. DeepTek CXR Analyzer automatically identifies, categorizes, and highlights suspicious regions of interest (ROIs) on chest X-rays, generating secondary capture DICOM with AI output for easy interpretation.
Tempus ECG-Low EF is intended for use in Cardiology, Emergency Medicine, and Internal Medicine. DeepTek CXR Analyzer primarily supports specialists in Cardiology, Pulmonology, and Radiology.
Tempus ECG-Low EF is deployed as software integrated into healthcare facility workflows. DeepTek CXR Analyzer offers seamless DICOM-based PACS integration and can be deployed either on-premise or via the cloud, operating in the background without altering current workflows.
Tempus ECG-Low EF aims to add a tool for clinicians to identify patients at risk for serious cardiovascular conditions earlier in their care journey. DeepTek CXR Analyzer is designed to reduce radiologist workload by 30-50% and boost productivity by 2x-3x by automating the detection and highlighting of pathologies.
Tempus ECG-Low EF detects signs associated with low left ventricular ejection fraction (LVEF u226440%), which can indicate heart failure, cardiomyopathy, or damage from a prior heart attack. DeepTek CXR Analyzer detects cardiac pathologies on chest X-rays as part of its 28 findings, alongside lung, pleural pathologies, and hardware.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.